Nexplanon and Combined Oral Contraceptive (COC) Combined Use Study

• Status: Completed
• Trial end date: 2017-07-26
• Target enrollment: 0
• Participant gender: Female

Summary

Women currently using or starting a combined oral contraceptive will be offered study enrollment. Study subjects will have a Nexplanon placed and followed for 6 months to evaluate if they continue the COC, continue the implant, or both, and to assess adverse events and bleeding patterns.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of California, Davis
• Collaborator: Merck Sharp & Dohme Corp.
• Treatments: Contraceptive Agents; Desogestrel; Etonogestrel

Criteria

Inclusion:

• Women being seen in a UC Davis medical office or who contact our research office.

• Potential participants must be women currently COCs or intending to initiate COCs at the time of the office visit.

Exclusion:

• Women who have contraindications to using a COC or a contraceptive implant (Category 3 or 4 in the CDC Medical Eligibility Criteria) will be excluded.

• Adults unable to consent

• Individuals who are not yet adults (infants, children, teenagers)

• Pregnant women

• Prisoners